IL156100A0 - Crystalline glucosamine sulphate metal salts - Google Patents

Crystalline glucosamine sulphate metal salts

Info

Publication number
IL156100A0
IL156100A0 IL15610001A IL15610001A IL156100A0 IL 156100 A0 IL156100 A0 IL 156100A0 IL 15610001 A IL15610001 A IL 15610001A IL 15610001 A IL15610001 A IL 15610001A IL 156100 A0 IL156100 A0 IL 156100A0
Authority
IL
Israel
Prior art keywords
metal salts
glucosamine sulphate
crystalline glucosamine
novel crystalline
present
Prior art date
Application number
IL15610001A
Other languages
English (en)
Original Assignee
Nicholas Piramal India Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas Piramal India Ltd filed Critical Nicholas Piramal India Ltd
Publication of IL156100A0 publication Critical patent/IL156100A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06—Aminosugars
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04—Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL15610001A 2000-12-01 2001-12-03 Crystalline glucosamine sulphate metal salts IL156100A0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1088MU2000 2000-12-01
IN1087MU2000 2000-12-01
IN394MU2001 2001-04-26
PCT/IN2001/000211 WO2002043653A2 (en) 2000-12-01 2001-12-03 Crystalline glucosamine sulphate metal salts

Publications (1)

Publication Number Publication Date
IL156100A0 true IL156100A0 (en) 2003-12-23

Family

ID=27272463

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15610001A IL156100A0 (en) 2000-12-01 2001-12-03 Crystalline glucosamine sulphate metal salts
IL156100A IL156100A (en) 2000-12-01 2003-05-25 Crystalline glucosamine sulphate metal salts, methods for their preparation and pharmaceutical compositions containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL156100A IL156100A (en) 2000-12-01 2003-05-25 Crystalline glucosamine sulphate metal salts, methods for their preparation and pharmaceutical compositions containing them

Country Status (29)

Country Link
US (1) US6812223B2 (bg)
EP (1) EP1347986B1 (bg)
JP (1) JP4307072B2 (bg)
KR (1) KR100842400B1 (bg)
CN (1) CN100351261C (bg)
AT (1) ATE293122T1 (bg)
AU (2) AU1741602A (bg)
BG (1) BG107845A (bg)
BR (1) BR0115801A (bg)
CA (1) CA2436925C (bg)
CZ (1) CZ20031503A3 (bg)
DE (1) DE60110118T2 (bg)
DK (1) DK1347986T3 (bg)
DZ (1) DZ3450A1 (bg)
EA (1) EA006632B1 (bg)
ES (1) ES2240570T3 (bg)
HR (1) HRP20030400A2 (bg)
HU (1) HU229546B1 (bg)
IL (2) IL156100A0 (bg)
MA (1) MA25925A1 (bg)
MX (1) MXPA03004693A (bg)
NO (1) NO324847B1 (bg)
NZ (1) NZ526079A (bg)
PL (1) PL207740B1 (bg)
PT (1) PT1347986E (bg)
RO (1) RO121738B1 (bg)
SI (1) SI21188A (bg)
SK (1) SK285926B6 (bg)
WO (1) WO2002043653A2 (bg)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20012818A1 (it) * 2001-12-28 2003-06-28 Acraf Un metodo per preparare un composto della glucosammina e composto cosi ottenuto
AU2003280305B2 (en) 2002-07-01 2008-05-01 Arkion Life Sciences Llc Process and materials for production of glucosamine and N-acetylglucosamine
US7388000B1 (en) 2004-09-17 2008-06-17 Jfct Technologies, Llc Halide-free glucosamine phosphate compositions and methods of preparation
US7388001B1 (en) 2004-09-17 2008-06-17 Jfc Technolries, Llc Halide-free glucosamine sulfate compositions and methods of preparation
US7683042B1 (en) 2004-09-17 2010-03-23 Jfc Technologies, Llc Stabilized halide-free glucosamine base and method of preparation
US7511134B1 (en) 2004-09-22 2009-03-31 Jfc Technologies Method for preparing N-acetylglucosamine
DE102005033844A1 (de) * 2005-07-20 2007-02-01 Beiersdorf Ag Insektenabwehrmittel mit Langzeitwirkung
US7854956B2 (en) * 2007-03-07 2010-12-21 Exportadora De Sal, S.A. De C.V. Low sodium salt compositions and methods of preparation and uses thereof
CN101735283B (zh) * 2008-11-14 2012-07-18 徐州海吉亚生物制品有限公司 一种氨基葡萄糖盐酸盐与氨基葡萄糖硫酸钾/钠盐的共结晶技术
CA2779168A1 (en) * 2009-11-05 2011-05-12 Pharma Base India Pvt. Ltd. Process for preparing a mixed salt of glucosamine sulfate and an alkali metal chloride
CN106866751B (zh) * 2017-02-17 2019-11-05 江苏双林海洋生物药业有限公司 一种硫酸氨基葡萄糖复盐的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1148050B (it) * 1981-04-30 1986-11-26 Rotta Research Lab Composto stabile della glucosamina solfato procedimento per la sua preparazione e composizioni farmaceutiche contenenti tale composto
DE3532081A1 (de) * 1985-09-09 1987-03-12 Orion Yhtymae Oy Mischsalze von glucosaminsulfat und verfahren zu ihrer herstellung
CH690719A5 (it) * 1996-08-19 2000-12-29 Rotta Res B V Amsterdam Swiss Procedimento per la preparazione di sali misti della glucosamina.
US5843923A (en) * 1998-05-22 1998-12-01 Jame Fine Chemicals, Inc. Glucosamine sulfate potassium chloride and process of preparation thereof

Also Published As

Publication number Publication date
JP4307072B2 (ja) 2009-08-05
PL366386A1 (en) 2005-01-24
MA25925A1 (fr) 2003-10-01
HU229546B1 (hu) 2014-01-28
EA006632B1 (ru) 2006-02-24
MXPA03004693A (es) 2005-04-19
KR100842400B1 (ko) 2008-07-01
KR20030055336A (ko) 2003-07-02
IL156100A (en) 2009-09-01
AU2002217416B2 (en) 2007-02-08
US20040030121A1 (en) 2004-02-12
CN100351261C (zh) 2007-11-28
BR0115801A (pt) 2005-12-13
EP1347986B1 (en) 2005-04-13
DE60110118T2 (de) 2006-03-02
HRP20030400A2 (en) 2005-10-31
AU1741602A (en) 2002-06-11
WO2002043653A2 (en) 2002-06-06
SK6482003A3 (en) 2003-09-11
DE60110118D1 (de) 2005-05-19
EA200300614A1 (ru) 2004-10-28
NO20032491L (no) 2003-07-30
EP1347986A4 (en) 2004-01-21
HUP0302154A2 (hu) 2003-10-28
BG107845A (bg) 2004-08-31
SK285926B6 (sk) 2007-11-02
CA2436925A1 (en) 2002-06-06
ATE293122T1 (de) 2005-04-15
PT1347986E (pt) 2005-08-31
DK1347986T3 (da) 2005-08-15
HUP0302154A3 (en) 2006-01-30
CA2436925C (en) 2008-10-14
EP1347986A2 (en) 2003-10-01
WO2002043653B1 (en) 2003-05-22
CN1479744A (zh) 2004-03-03
US6812223B2 (en) 2004-11-02
SI21188A (sl) 2003-10-31
CZ20031503A3 (cs) 2003-10-15
RO121738B1 (ro) 2008-03-28
JP2004529860A (ja) 2004-09-30
WO2002043653A3 (en) 2003-01-03
NO20032491D0 (no) 2003-06-02
NZ526079A (en) 2005-07-29
PL207740B1 (pl) 2011-01-31
ES2240570T3 (es) 2005-10-16
DZ3450A1 (fr) 2002-06-06
NO324847B1 (no) 2007-12-17

Similar Documents

Publication Publication Date Title
IL156100A0 (en) Crystalline glucosamine sulphate metal salts
MX2009003305A (es) Inhibidores de co-transportador de glucosa de sodio 2 y metodo para su uso.
MXPA05008172A (es) Derivados de malonamida como inhibidores gamma-secretasa.
RU2005115855A (ru) Композиция трамадола продлонгированного высвобождением с 24-часовым действием
MX2009004104A (es) Terapia combinada con inhibidores de sglt-2 y sus composiciones farmaceuticas.
NZ527311A (en) Composition for heart disease, method to prepare same and uses thereof
RU2008118101A (ru) Смесь солей железа и меди, маскирующая металлический вкус
BRPI0520050A2 (pt) composto, processo para a preparação de um composto e processo de glicosilação estereoseletiva para a preparação de mais de 99% de anÈmero b enriquecido de hidrocloreto de gencitabina
IL187220A0 (en) Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment of urogenital cancer and its metastasis
NZ581390A (en) Prebiotics comprising an oligosaccharide, sialyloligosaccharide and free sialic acid
WO2004017998A3 (en) Topical emulsion- gel composition comprising diclofenac sodium
CA2632207C (en) Use of calcitonin for the treatment of ra
IL156827A (en) Derivatives of 2-mercapto- [3,1] thiazolo [4,5 [b- pyridine and pharmaceutical preparations containing them for the treatment of cardiovascular disease
CA2527365A1 (en) Compositions for prevention and treatment of cold and influenza-like symptoms comprising chelated zinc
AU2003269146A1 (en) Process for the preparation of sodium ferric gluconate complex in sucrose
LT2003051A (en) Crystalline glucosamine sulphate metal salts and process for preparing the same
WO2006017590A3 (en) Use of methyl pyruvate for the purpose of reducing weight gain in mammals
WO2003094905A8 (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
WO2006015232A3 (en) Use of methyl pyruvate for the purpose of increasing muscle energy production
WO2002098843A3 (en) Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors
FR2849601B1 (fr) Nouvelles compositions synergiques de boissons stimulant le metabolisme cellulaire pour ameliorer l'efficacite des extraits de plantes
ECSP034670A (es) Sales de metal cristalinas de sulfato de glucosamina y procedimientos para su preparacion
NZ607724A (en) Topical medicament for treating or preventing pain
WO2002068056A3 (en) Combination comprising a 1,4-dioxonaphathalene compound and ribenoside
TW200602057A (en) Medicaments containing n-sulfamoyl-n' -arylpiperazines for the prophylaxis or treatment of obesity and related conditions